no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Announcements
|
|
|
1995 |
10 |
1 |
p. 63-64 |
article |
2 |
Clinical significance of inverted PSA/PAP ratio in prostate cancer patients
|
Morote, J. |
|
1995 |
10 |
1 |
p. 58 |
article |
3 |
Cyfra 21-1 in Bronchoalveolar Lavage: Preliminary Results
|
Blasco, R.F. |
|
1995 |
10 |
1 |
p. 55-57 |
article |
4 |
DNA content in human colon cancer and non-neoplastic adjacent mucosa
|
Jotti, G. Saccani |
|
1995 |
10 |
1 |
p. 11-16 |
article |
5 |
Effects of granulocyte colony stimulating factor on the specific macrophage marker neopterin in cancer patients
|
Lissoni, P. |
|
1995 |
10 |
1 |
p. 61-62 |
article |
6 |
Eosinophilia induced by interleukin-2 cancer immunotherapy may be associated with enhanced production of total IgE
|
Vecchi, L. |
|
1995 |
10 |
1 |
p. 59-60 |
article |
7 |
Immunocytochemical determination of the tumor-associated glycoproteins MCA, CA 125 and BW 495/36-P in urine of patients with epithelial tumors of the kidney and urinary bladder
|
Ammon, A. |
|
1995 |
10 |
1 |
p. 17-23 |
article |
8 |
Longitudinal follow-up of breast cancer patients with the tumor markers CA 549 and CA 15.3
|
Vankrieken, L. |
|
1995 |
10 |
1 |
p. 30-34 |
article |
9 |
Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples
|
Drivsholm, L. |
|
1995 |
10 |
1 |
p. 1-4 |
article |
10 |
Progesterone agonists and antagonists induce down– and up–regulation of estrogen receptors and estrogen inducible genes in human breast cancer cell lines
|
Savoldi, G. |
|
1995 |
10 |
1 |
p. 47-54 |
article |
11 |
Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer
|
Diez, M. |
|
1995 |
10 |
1 |
p. 5-10 |
article |
12 |
Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer
|
Reale, M.G. |
|
1995 |
10 |
1 |
p. 42-46 |
article |
13 |
Study of serum tumor markers CEA, CA 15.3 and CA 27.29 as diagnostic parameters in patients with breast carcinoma
|
De Paterna, L. Rodríguez |
|
1995 |
10 |
1 |
p. 24-29 |
article |
14 |
The clinical value of CEA and CA 15-3 in breast cancer management
|
Coveney, E.C. |
|
1995 |
10 |
1 |
p. 35-41 |
article |